Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
01 December 2025
Announcement After the FDA approved Otsuka’s anti-APRIL antibody sibeprenlimab to alleviate the urine protein level in the IgA nephropathy patient group, this approved drug will be commerciali...
28 November 2025
Announcement Phio Pharmaceuticals Corp., a clinical-level siRNA biopharmaceutical company establishing a therapeutic game with its exclusive INTASYL® gene silencing technology to treat cancer, h...
28 November 2025
Announcement Novartis’ intrathecal form of spinal muscular atrophy gene therapy, Zolgensma, received FDA approval. With this approval, Novartis will expand access to this therapy, reaching pat...
27 November 2025
Announcement Bristol Myers Squibb proudly confirmed that they have officially received a European Commission’s approval stamp on Breyanzi® potential, a CD19-directed chimeric antigen recept...
27 November 2025
Announcement NervGen’s robust investigational peptide therapeutic, NVG-291, has successfully enhanced the quality of life and improved functional performance in a patient group having chronic ...
26 November 2025
Announcement After getting near the end of the tunnel with the AAVantgarde closing of the Series B financing round, AGC Biologics is preparing for a new manufacturing agreement with the biotechnolog...
25 November 2025
Announcement Concept Life Sciences, a known contract research organisation (CRO) delivering to the global pharma and Life Sciences industry, has proudly declared that it showcased three new research...
24 November 2025
Announcement Agios Pharmaceuticals, Inc., a marketing-level biopharmaceutical company attentive on serving the best innovative medicines for patient groups with rare diseases, have unveiled its prom...
24 November 2025
Announcement Alzheon Inc., a clinical-level biopharmaceutical company upgrading in diagnostics and therapeutics for the Alzheimer’s disease (AD) patient group, has confirmed that they will pre...
21 November 2025
Announcement HCW Biologics Inc., a US-based clinical-level biopharmaceutical company aimed at establishing and exploring new innovative immunotherapies to expand healthspan by focusing on the connec...
Speak with a healthcare analyst about your research, consulting, or platform needs.